A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer
Titel:
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer
Auteur:
Sternberg, C.N. Saad, F. Graff, J.N. Peer, A. Vaishampayan, U.N. Leung, E. Rosenbaum, E. Gurney, H. Epstein, R.J. Davis, I.D. Wu, B. Trandafir, L. Wagner, V.J. Hussain, M.